Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
169.4 USD | +0.50% | +5.07% | +9.32% |
12:18am | Top law firms in US opioid lawsuits to get hundreds of millions in fees | RE |
Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
Official Publications
SEC Filing 10Q-1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
Shareholders meeting voting results | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Official Publications